slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 44,581-44,610
Pages 10,126
Rows per page 30
Component
44,581-44,610 of 303,780
09
The chart highlights a 'Synchronized concentration peak' at 5 hours for both PrimeC components.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution2 hits
11
Includes details on screen failures and misdiagnosis exclusions.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution2 hits
17
The slide highlights a 37.4% reduction in disease progression with statistical significance (p=0.03) in the per-protocol population, while noting a 29% reduction in the ITT analysis.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Before After2 hits
19
The chart visualizes the reduction in points lost, highlighting a 3.22 point difference (p=0.03).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
20
The slide uses a human body diagram to categorize ALS symptoms and bar charts to show the reduction in point loss (slower disease progression) for each category.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution2 hits
21
The chart highlights a 17.2% attenuation in the decline of SVC score for the PrimeC group compared to placebo.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations Beat · Solution2 hits
26
The slide outlines the methodology for a Phase 2 clinical trial for Alzheimer's Disease (AD).NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 2 hits
31
The chart shows a clear divergence between the treatment and placebo groups over time, with error bars indicating variability.NeuroSense Therapeutics | Investor Presentation Deck | 33 slides · NeuroSense Therapeutics
Pitch deck Investor relations 2 hits
02
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Problem2 hits
04
The slide uses a split layout: team members on the left and their associated track record (logos) on the right.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
08
Includes a detailed biological pathway diagram created with BioRender.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
09
The slide demonstrates superior tumor growth inhibition by NXP800 compared to Cisplatin in both resistant and sensitive models.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction2 hits
10
Includes a patient MRI, a schematic of the PDX study design, a line chart showing tumor volume over time, and photographic evidence of tumor size reduction.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size2 hits
12
Includes footnotes regarding NGS panels and weighted average calculations.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Market Size2 hits
17
The slide uses a structural biology mechanism of action (MOA) comparison to demonstrate competitive advantage.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · CompetitionLoop · Quick Win Big Bet2 hits
18
Includes a biological pathway diagram, microscopy images, and an IC50 dose-response curve.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Loop · Quick Win Big Bet2 hits
23
Nuvectis Pharma | Investor Presentation Deck | 25 slidesNuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · Financials2 hits
01
The slide features a branded orange banner across a closet image.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations 2 hits
09
The slide uses a 5-column grid layout to present strategic pillars paired with supporting evidence.SiriusXM | Investor Presentation Deck | 16 slides · SiriusXM
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
08
SiriusXM | Investor Presentation Deck | 20 slidesSiriusXM | Investor Presentation Deck | 20 slides · SiriusXM
Conference presentation Investor relations Beat · Solution2 hits
11
The slide uses a stacked bar chart to illustrate the discrepancy between population size and audio spend, segmenting the audience into 'Core' and 'Growth'.SiriusXM | Investor Presentation Deck | 20 slides · SiriusXM
Conference presentation Investor relations Beat · Market Size2 hits
12
Includes logos of partner networks and platforms.SiriusXM | Investor Presentation Deck | 20 slides · SiriusXM
Conference presentation Investor relations Beat · Market Size2 hits
01
Skillsoft | Results Presentation Deck | 15 slidesSkillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · Setup2 hits
07
The chart is a stacked bar chart showing the composition of bookings over time.Skillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In2 hits
08
The chart shows a stacked bar comparison of revenue across six quarters (Q1 '23 to Q3 '24).Skillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In2 hits
09
Skillsoft | Results Presentation Deck | 15 slidesSkillsoft | Results Presentation Deck | 15 slides · Skillsoft
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In2 hits
08
The slide emphasizes the ecosystem value of the platform through cloud integration and third-party automation.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Loop · Golden Circle2 hits
15
Includes a map showing nationwide reach from Vegas and a customer journey process flow.Vivid Seats | Investor Presentation Deck | 24 slides · Vivid Seats
Pitch deck Investor relations Loop · Golden Circle2 hits
22
The slide uses a high-quality photograph of artisanal tailoring to reinforce the 'Italian' and 'integrated' aspects of the brand.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction2 hits
49
This is a brand-heavy filler slide from a Thom Browne presentation.Zegna | Investor Day Presentation Deck | 150 slides · Zegna
Conference presentation Investor relations Beat · ActionLoop · Quick Win Big Bet2 hits